New York, NY -- (SBWIRE) -- 12/24/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Ballard Power Systems Inc. (USA) (NASDAQ:BLDP), Cincinnati Bell Inc (NYSE:CBB), Inovio Pharmaceuticals Inc (NYSEMKT:INO)
Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) showed a volume of 1.19 million shares by the end of last trade whereas the average volume of the stock remained 1.67 million shares. The stock opened the session at $1.55 but then moved to $1.50. At that price, the stock showed a negative performance of -1.32%. Ballard Power Systems Inc. (Ballard) is engaged in design, development, manufacture, sale and service of fuel cell products for a variety of applications, focusing on motive power (material handling and buses) and stationary power (back-up power and distributed generation). It is also engaged in proton exchange membrane (PEM) fuel cell development and commercialization. The Company provides engineering services for a variety of fuel cell applications. It operates in two segments: Fuel Cell Products and Material Products. Its product and services include fuel cell stacks, fuel cell modules,
Will BLDP Get Buyers Even After The Recent Rally? Find Out Here
Cincinnati Bell Inc (NYSE:CBB) opened the session at $3.60 and closed the session at $3.61. The stock showed a positive performance of 0.28% in previous trading session. Traded with volume of 1.06 million shares in the prior session and the average volume of the stock remained 1.33 million shares. Cincinnati Bell Inc is a full-service provider of data and voice communications services over wireline and wireless networks, a full-service provider of data center colocation and related managed services, and a reseller of information technology (IT) and telephony equipment. The Company provides telecommunications service to businesses and consumers in the Greater Cincinnati and Dayton areas on its owned wireline and wireless networks.
For How Long CBB will fight for Profitability? Read This Trend Analysis report
Inovio Pharmaceuticals Inc (NYSEMKT:INO) opened the session at $2.20 and closed the session at $2.40. The stock showed a positive performance of 11.63% in previous trading session. Traded with volume of 12.43 million shares in the prior session and the average volume of the stock remained 3.03 million shares. The beta of the stock remained 3.18. novio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV). The Company's electroporation delivery technology uses brief, controlled electrical pulses to increase cellular uptake of the vaccine. The Company's clinical programs include cervical dysplasia (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic),
Why Should Investors Buy INO After The Recent Gain? Just Go Here and Find Out
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)